1 out of 3 patients

Admitted to the hospital require treatment with heparin - for example in the case of cardiovascular disease, surgical procedures, and hemodialysis

1 billion pigs

Are required yearly to meet the global demand for heparin as it is produced as an extract of the mucosal lining of pig intestines

80 % of global heparin supply comes from China

This poses many risks to supply security, safety and sustainability for geopolitical reasons as well as environmental such as the recurring outbreaks of African Swine Fever

FDA listed shortage

Of heparin since 2017 however there is an increasing demand for heparin for its standard applications as well as new indications